Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Q and A with Rick Goerner
1
Jun 04, 2008 12:44PM

Selective expansion of our IP portfolio by acquiring new IP:
We have identified several patent portfolios to expand our MMP™ portfolio licensing efforts through TPL, our exclusive licensing partner. These IP portfolios involve microcontroller, power management, embedded memory and mobile networking IP.

Oh yea, more patents, more prior art USTPO reviews, more secrecy, &
more litigation all with no transparancy and TPL calling the
shots......sheesh, I can't wait......

Then again, just for laughs, let's say Patriot acquired some patents
and had TPL/PDS negotiate the licensing. How much are we going to
give away for them to actively pursue signings with the same energy
over the MMP portfolio & the Alliacense portfolio as it is now? I'm
not sure I'm liking this situation....

Share
New Message
Please login to post a reply